Clinical Trial Update: Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov update notes a completed Phase 1/2 study evaluating a combination of 5-fluorouracil, interferon-alpha, interleukin-2, and thalidomide for met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Adrucil (5-fluorouracil)
• Intron A (interferon alfa-2b)
• Proleukin (aldesleukin)
• Thalomid (thalidomide)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Kidney, Cancer | Phase 1, Phase 2 | Status: COMPLETED